<em>RAC1</em> as a potential pan-cancer diagnostic, prognostic, and immunological biomarker

CONCLUSIONS: This extensive solid tumor analysis provides sound evidence that RAC1 can serve as both as an immunotherapy target and as a diagnostic and prognostic …